Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003915 |
---|---|
Receipt number | R000004706 |
Scientific Title | Cohort study of XELOX in combination with bevacizumab for unresectable or recurrent colorectal cancer |
Date of disclosure of the study information | 2010/07/14 |
Last modified on | 2017/01/13 13:42:08 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/07/14 19:10:54 | ||
2 | Update | 2010/07/15 12:20:41 | UMIN ID1 |
|
3 | Update | 2010/07/15 12:32:38 | Organization1 Tel1 Email1 |
|
4 | Update | 2011/01/14 11:11:37 | Email |
|
5 | Update | 2011/04/06 10:52:21 | Recruitment status |
|
6 | Update | 2011/04/06 12:42:25 | Institutions |
|
7 | Update | 2012/01/17 15:48:13 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
8 | Update | 2012/02/14 09:07:30 | Category of Funding Organization |
|
9 | Update | 2013/11/20 09:25:50 | Publication of results Results |
|
10 | Update | 2014/01/14 21:20:11 | TEL Last name of contact person Last name of contact person |
|
11 | Update | 2015/05/22 08:05:11 | Email |
|
12 | Update | 2016/01/14 18:34:53 | Recruitment status Publication of results URL related to results and publications |
|
13 | Update | 2016/02/24 19:08:15 | Acronym Acronym |
|
14 | Update | 2017/01/13 13:39:36 | Name of primary person or sponsor Organization |
|
15 | Update | 2017/01/13 13:41:53 | URL related to results and publications |
|
16 | Update | 2017/01/13 13:42:08 | Public title |